Newsroom

HOUSTON--(BUSINESS WIRE)--Comfort Systems USA, Inc. (NYSE: FIX), a leading provider of mechanical and electrical contracting services including heating, ventilation, air conditioning, plumbing, electrical, piping and controls, announces that it has scheduled its quarterly conference call and webcast for Friday, April 24, 2026, at 10:00 a.m. Central Time to discuss first quarter 2026 financial results. The results will be released after the market closes on Thursday, April 23, 2026. The conferen...

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to new employees. On April 14, 2026, the Compensation Committee of Savara's Board of Directors granted the inducement awards to 24 new employees who recently joined the Company. The inducement awards consist of options to purchase 18,500 shares of the Company’s common stock, restricted stock units (RSUs) cove...

LIVINGSTON, N.J.--(BUSINESS WIRE)--CoreWeave, Inc. (Nasdaq: CRWV), The Essential Cloud for AI™, will hold its quarterly conference call to discuss first quarter 2026 financial results on Thursday, May 7, 2026 at 5:00 PM Eastern Time. The live webcast of the earnings conference call can be accessed at the CoreWeave Investor Relations website at investors.coreweave.com. A replay of the webcast will be available at the same website. About CoreWeave, Inc. CoreWeave is The Essential Cloud for AI™. B...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its first quarter 2026 financial results after U.S. markets close on Wednesday, May 6, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 7, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business o...

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of QVC, Inc. (the “Company”) from the Exchange. Trading in the Company’s Securities will be suspended immediately. Symbol Description QVCC 6.250% Senior Secured Notes due 2068 QVCD 6.375% Senior Secured Notes due 2067 NYSE Regulation reached its decision that the Compa...

INDIANAPOLIS--(BUSINESS WIRE)--hc1®, the leader in agentic lab data intelligence for healthcare, today announced that its Founder, Chairman, and CEO, Bradley Bostic, has been named to the prestigious Crain's Chicago Business Notable Leaders in Health Care 2026 list. This recognition highlights Bostic's commitment to advancing healthcare delivery by utilizing AI-driven insights to maximize cost savings, reduce waste, and drive operational efficiency across comprehensive health systems. Under Bos...

BOSTON--(BUSINESS WIRE)--Eaton Vance Limited Duration Income Fund (NYSE: EVV), Eaton Vance Senior Floating-Rate Trust (NYSE: EFR), and Eaton Vance Senior Income Trust (NYSE: EVF) (each a “Fund,” and together, the “Funds”) announced that the Board of Trustees of each Fund has authorized each Fund to conduct a voluntary tender offer for up to 100% of its outstanding auction preferred shares (“APS”) at a price per share equal to 98% of the APS liquidation preference of $25,000 per share (or $24,50...

CANTON, Massachusetts--(BUSINESS WIRE)--Orthogon Therapeutics a annoncé aujourd’hui la clôture d’un tour de table de 11 millions de dollars, portant le montant total des fonds levés par l’entreprise à 36 millions de dollars. Ce financement permettra à l’entreprise de poursuivre le développement de son médicament innovant contre le polyomavirus BK. Les infections par ce virus constituent une cause majeure de complications chez les patients ayant reçu une greffe d’organe, et aucun traitement n’es...

BOSTON--(BUSINESS WIRE)--MassEcon honors Avangrid for growing the Massachusetts economy and strengthening the Commonwealth’s ability to compete in the global economy...

CANTON, Massachusetts--(BUSINESS WIRE)--Orthogon Therapeutics gab heute den Abschluss einer Folgefinanzierung in Höhe von 11 Millionen US-Dollar bekannt, womit sich das insgesamt eingeworbene Kapital auf 36 Millionen US-Dollar erhöht. Die Finanzierung ermöglicht die weitere Entwicklung des First-in-Class-Medikaments gegen das BK-Polyomavirus. BK-Virus-Infektionen sind eine der Hauptursachen für Komplikationen bei Transplantationspatienten, wobei es bislang keine zugelassenen Behandlungsmethoden...